THC240719P120000
- 0.10
- 0.000.00%
Tenet Healthcare Newsroom
Tenet Healthcare Is Maintained at Buy by Truist Securities
Tenet Healthcare Is Maintained at Buy by Truist
Truist Financial Maintains Tenet Healthcare(THC.US) With Buy Rating, Raises Target Price to $155
Truist Financial analyst David S Macdonald maintains $Tenet Healthcare(THC.US)$ with a buy rating, and adjusts the target price from $130 to $155.According to TipRanks data, the analyst has a
Express News | Tenet Healthcare Corp : Truist Securities Raises Target Price to $155 From $130
Here's Why Tenet Healthcare (THC) Gained But Lagged the Market Today
Peering Into Tenet Healthcare's Recent Short Interest
Tenet Healthcare's (NYSE:THC) short percent of float has fallen 8.9% since its last report. The company recently reported that it has 4.60 million shares sold short, which is 6.14% of all regular
Express News | Tenet Healthcare Corp : Mizuho Raises Target Price to $145 From $130
Is Tenet Healthcare (THC) Stock Undervalued Right Now?
Some Confidence Is Lacking In Tenet Healthcare Corporation's (NYSE:THC) P/S
It's not a stretch to say that Tenet Healthcare Corporation's (NYSE:THC) price-to-sales (or "P/S") ratio of 0.6x right now seems quite "middle-of-the-road" for companies in the Healthcare industry
Express News | Barclays Maintains Overweight on Tenet Healthcare, Raises Price Target to $156
$1000 Invested In This Stock 15 Years Ago Would Be Worth $10,000 Today
Tenet Healthcare (NYSE:THC) has outperformed the market over the past 15 years by 3.74% on an annualized basis producing an average annual return of 16.47%. Currently, Tenet Healthcare has a market
Tenet Healthcare (THC) Is a Top-Ranked Value Stock: Should You Buy?
Express News | Tenet Healthcare Inc. : Barclays Raises Target Price to $156 From $147
Barclays Maintains Tenet Healthcare(THC.US) With Buy Rating, Raises Target Price to $156
Barclays analyst Andrew Mok CFA maintains $Tenet Healthcare(THC.US)$ with a buy rating, and adjusts the target price from $147 to $156.According to TipRanks data, the analyst has a success rate of 44.
Barclays Sticks to Its Buy Rating for Tenet Healthcare (THC)
Tenet Healthcare Price Target Maintained With a $112.00/Share by Cantor Fitzgerald
Tenet Healthcare Price Target Maintained With a $112.00/Share by Cantor
Zacks.com Featured Highlights Include Tenet Healthcare, Leidos Holdings, Atmos Energy and Cabot
Tenet Healthcare Stock: A Deep Dive Into Analyst Perspectives (13 Ratings)
In the last three months, 13 analysts have published ratings on Tenet Healthcare (NYSE:THC), offering a diverse range of perspectives from bullish to bearish.The table below offers a condensed view of
Deutsche Bank's Fresh Money List for 3Q
Express News | Cantor Fitzgerald Reiterates Overweight on Tenet Healthcare, Maintains $112 Price Target
Express News | Tenet Healthcare Corp : Stephens Raises Target Price to $141 From $122